1.22 USD
-0.03 (-2.4%)
BIVI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. While BIVI has a great health rating, there are worries on its profitability. BIVI is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year BIVI has reported negative net income.
- In the past year BIVI has reported a negative cash flow from operations.
- In the past 5 years BIVI always reported negative net income.
- In the past 5 years BIVI always reported negative operating cash flow.
1.2 Ratios
- BIVI's Return On Assets of -69.22% is on the low side compared to the rest of the industry. BIVI is outperformed by 62.29% of its industry peers.
- BIVI has a Return On Equity (-74.50%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -69.22% | ||
| ROE | -74.5% | ||
| ROIC | N/A |
ROA(3y)-119.07%
ROA(5y)-705.14%
ROE(3y)-211.57%
ROE(5y)-997.19%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- BIVI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The number of shares outstanding for BIVI has been increased compared to 1 year ago.
- Compared to 5 years ago, BIVI has more shares outstanding
- BIVI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- BIVI has an Altman-Z score of -17.01. This is a bad value and indicates that BIVI is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of BIVI (-17.01) is worse than 80.76% of its industry peers.
- There is no outstanding debt for BIVI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -17.01 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 15.83 indicates that BIVI has no problem at all paying its short term obligations.
- BIVI's Current ratio of 15.83 is amongst the best of the industry. BIVI outperforms 92.57% of its industry peers.
- A Quick Ratio of 15.83 indicates that BIVI has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 15.83, BIVI belongs to the top of the industry, outperforming 92.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 15.83 | ||
| Quick Ratio | 15.83 |
3. Growth
3.1 Past
- BIVI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.36%, which is quite impressive.
EPS 1Y (TTM)84.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.94%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- The Earnings Per Share is expected to grow by 60.24% on average over the next years. This is a very strong growth
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y33.11%
EPS Next 2Y72.68%
EPS Next 3Y69.51%
EPS Next 5Y60.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- BIVI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- The Price/Forward Earnings ratio is 0.28, which indicates a rather cheap valuation of BIVI.
- BIVI's Price/Forward Earnings ratio is rather cheap when compared to the industry. BIVI is cheaper than 99.81% of the companies in the same industry.
- BIVI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.98.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 0.28 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as BIVI's earnings are expected to grow with 69.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.68%
EPS Next 3Y69.51%
5. Dividend
5.1 Amount
- BIVI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BIOVIE INC / BIVI FAQ
What is the fundamental rating for BIVI stock?
ChartMill assigns a fundamental rating of 3 / 10 to BIVI.
Can you provide the valuation status for BIOVIE INC?
ChartMill assigns a valuation rating of 4 / 10 to BIOVIE INC (BIVI). This can be considered as Fairly Valued.
How profitable is BIOVIE INC (BIVI) stock?
BIOVIE INC (BIVI) has a profitability rating of 0 / 10.
What is the expected EPS growth for BIOVIE INC (BIVI) stock?
The Earnings per Share (EPS) of BIOVIE INC (BIVI) is expected to grow by 33.11% in the next year.